JPRN-UMIN000024208招募中未知
Ranibizumab Exploratory Study on the Evaluation of the local laser combination therapy to non-reactive group to the diabetic macular edema patients - RELAND study
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with a treatment history of anti VEGF drugs patients 2) Patients with infection or infection suspictions in the eye or around the eye 3) Patients with severe inflammation in the eye 4) DME disease duration is more than 12 months 5) Patients who underwent direct photocoagulation to 3 months in DME within 1000um from the fovea 6) Patients who underwent triamcinolone acetonide subtenon injection or triamcinolone acetonide intravitreal injectionwithin 3 months 7) Patients who underwent PRP within 6 months 8) HbA1c is over 10.0% 9) Poor control of hypertension 10) Eye surgery within 6 months 11) ranibizumab or to the components of other anti-VEGF drugs, those with a history of hypersensitivity 12) Pregnancy, in nursing 13) Other, patient research responsibility who is determined to be unsuitable as research subjects
研究者
相似试验
进行中（未招募）
1 期
Ranibizumab (Lucentis) for treatment of Uveitic Macular Oedema (LIMO)veitic Macular OedemaMedDRA version: 20.0 Level: PT Classification code 10046851 Term: Uveitis System Organ Class: 10015919 - Eye disordersMedDRA version: 20.1 Level: PT Classification code 10058202 Term: Cystoid macular oedema System Organ Class: 10015919 - Eye disordersEUCTR2011-001869-41-GBMoorfields Eye Hospital NHS Foundation Trust20
进行中（未招募）
1 期
A prospective case series of Ranibizumab for the treatment of inflammatory and idiopathic choroidal neovascular membranes. - Ranibizumab for inflammatory choroidal neovascular membranesEUCTR2008-007476-19-GBniversity Hospitals Bristol NHS Trust15
进行中（未招募）
1 期
Investigating the rate of clearance of ranibizumab and aflibercept from the eyeMedDRA version: 17.0 Level: PT Classification code 10064930 Term: Age-related macular degeneration System Organ Class: 10015919 - Eye disordersAge-related macular degenerationMedDRA version: 17.0 Level: LLT Classification code 10067791 Term: Wet macular degeneration System Organ Class: 10015919 - Eye disordersEUCTR2012-005500-18-GBKing's College Hospital NHS Foundation Trust62
已完成
3 期
Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein OcclusionBranch Retinal Vein OcclusionNCT01599650Novartis Pharmaceuticals455
已完成
4 期
Safety and Tolerability of Ranibizumab in Mono/Bilateral Wet Age Related Macular Degeneration (w-AMD) Patients in Eyes With BCVA<2/10 and/or 2nd Affected EyeWet Age Related Macular DegenerationNCT01986907Novartis Pharmaceuticals1,049